ArticleViruses2022

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients.

Laura Thümmler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.